[ATRC] AtriCure, Inc.


Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 19.23 Change: 0.41 (2.15%)
Ext. hours: Change: 0 (0%)

chart ATRC

Refresh chart

Strongest Trends Summary For ATRC

ATRC is in the long-term up 74% in 6 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: AtriCure, Inc., a medical device company, provides atrial fibrillation solutions worldwide. It provides isolator bipolar radio-frequency (RF) ablation clamps that are used for ablation during open-heart procedures; and ablation and sensing unit, a compact power generator that provides the RF energy for its clamps, multifunctional pens, and coolrail linear ablation devices. The company also offers AtriCure Switch Box, a compact switch box, which offers the technology needed for the dual pulsing electrodes in isolator synergy clamps; isolator multifunctional pens that enable surgeons to evaluate cardiac arrhythmias, as well as to perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and coolrail linear ablation device, a disposable linear RF ablation device that allows physicians to create an expanded cardiac ablation lesion set during minimally invasive procedures. In addition, it provides RF ablation devices, such as COBRA Fusion Surgical Ablation System; C

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS-1.06 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 12.72% Sales Growth - Q/Q1.6% P/E-20.6
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-8.97% ROE-10.71% ROI-10.69%
Current Ratio3.79 Quick Ratio3.18 Long Term Debt/Equity Debt Ratio0.19
Gross Margin70.96% Operating Margin-12.07% Net Profit Margin-12.24% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities1.82 M Cash From Investing Activities2.56 M Cash From Operating Activities-8.97 M Gross Profit21.73 M
Net Profit-5.27 M Operating Profit-5.14 M Total Assets153.41 M Total Current Assets93.42 M
Total Current Liabilities24.63 M Total Debt6.08 M Total Liabilities24.85 M Total Revenue29.89 M
Technical Data
High 52 week35.58 Low 52 week22.87 Last close29.42 Last change-0.98%
RSI43.69 Average true range0.72 Beta0.63 Volume87.66 K
Simple moving average 20 days0.2% Simple moving average 50 days2.98% Simple moving average 200 days-4.84%
Performance Data
Performance Week-0.64% Performance Month8.04% Performance Quart-11.36% Performance Half-3.48%
Performance Year23.04% Performance Year-to-date-3.86% Volatility daily1.46% Volatility weekly3.27%
Volatility monthly6.69% Volatility yearly23.18% Relative Volume226.41% Average Volume263.75 K
New High New Low


2020-05-11 22:42:23 | Edited Transcript of ATRC earnings conference call or presentation 29-Apr-20 8:30pm GMT

2020-05-11 20:10:00 | AtriCure Announces Pricing of Public Offering of Common Stock

2020-05-11 07:16:00 | AtriCure Announces Proposed Public Offering of Common Stock

2020-05-08 08:47:00 | AtriCure Announces Results from CONVERGE IDE Clinical Trial

2020-04-30 11:00:56 | AtriCure Inc ATRC Q1 2020 Earnings Call Transcript

2020-04-30 08:30:00 | AtriCure Announces Investor Update Webcast on May 8, 2020 in Conjunction with the 41st Annual Heart Rhythm Society HRS Virtual Meeting

2020-04-29 17:25:09 | AtriCure ATRC Reports Q1 Loss, Tops Revenue Estimates

2020-04-29 16:01:00 | AtriCure Reports First Quarter 2020 Financial Results

2020-04-27 16:02:00 | AtriCure to Participate at Upcoming Investor Conferences

2020-04-22 12:31:04 | Analysts Estimate AtriCure ATRC to Report a Decline in Earnings: What to Look Out for

2020-04-15 08:00:00 | AtriCure to Announce First Quarter 2020 Financial Results

2020-04-14 06:42:00 | Some Analysts Just Cut Their AtriCure, Inc. NASDAQ:ATRC Estimates

2020-04-13 08:00:00 | AtriCure Announces CONVERGE IDE Trial Results Accepted for Late-Breaking Clinical Trial Sessions at Annual Heart Rhythm Society HRS Meeting

2020-04-09 12:26:00 | AtriCure C-suite taking pay cuts as revenue dips because of coronavirus

2020-04-09 08:00:00 | AtriCure Announces Preliminary Financial Results for First Quarter 2020 and Provides COVID-19 Pandemic Update

2020-04-06 16:14:10 | Dayton stocks reap massive gains as broad market skyrockets

2020-04-01 15:00:36 | Dayton stocks dive again after Q1 registers biggest drop since 2008

2020-03-24 17:09:20 | These Dayton stocks skyrocketed as market posts best day since 1933

2020-03-23 14:29:39 | Here's how Dayton stocks fared as Dow falls to lowest level since 2016

2020-03-23 14:29:39 | Here's how Dayton stocks fared as Dow falls to lowest level since 2016

2020-03-12 09:21:11 | Dayton stocks tumble as Dow falls, ending 11-year bull run

2020-02-28 14:53:38 | Dayton stocks face sharp declines as equity market tumbles

2020-02-21 21:56:31 | Edited Transcript of ATRC earnings conference call or presentation 18-Feb-20 9:30pm GMT

2020-02-20 05:54:56 | US$49.43 - That's What Analysts Think AtriCure, Inc. Is Worth After These Results

2020-02-18 16:01:00 | AtriCure Reports Fourth Quarter 2019 and Full Year 2019 Financial Results

2020-02-18 14:30:00 | AtriCure, Inc. to Host Earnings Call

2020-02-03 08:00:00 | AtriCure to Participate at the SVB Leerink 9th Annual Global Healthcare Conference

2020-01-31 07:33:16 | Is AtriCure NASDAQ:ATRC Using Debt Sensibly?

2020-01-28 11:15:52 | Here's how Dayton-area stocks performed in 2019

2020-01-28 08:00:00 | AtriCure to Announce Fourth Quarter and Full Year 2019 Financial Results

2020-01-10 08:14:01 | AtriCure Enters Overbought Territory

2020-01-07 08:00:00 | AtriCure Announces Successful Completion of Patient Enrollment of aMAZE Clinical Trial and FDA Approval of Continued Access Protocol

2019-12-16 08:00:00 | AtriCure to Participate at the 38th Annual JP Morgan Healthcare Conference

2019-12-10 11:28:22 | Why AtriCure CEO Mike Carrel wants title of ‘heart surgeon’ for a day

2019-12-09 13:12:18 | Did Hedge Funds Drop The Ball On AtriCure Inc. ATRC ?

2019-12-05 06:13:00 | Medical device maker south of Dayton gets board refresh

2019-12-04 08:00:00 | AtriCure Names Two Industry Veterans to Board of Directors

2019-12-02 09:33:54 | Is AtriCure, Inc.'s NASDAQ:ATRC CEO Paid Enough Relative To Peers?

2019-11-12 08:00:00 | AtriCure to Participate at the Piper Jaffray 31st Annual Healthcare Conference

2019-11-04 17:41:12 | Edited Transcript of ATRC earnings conference call or presentation 30-Oct-19 8:30pm GMT

2019-10-30 18:15:10 | AtriCure ATRC Reports Q3 Loss, Tops Revenue Estimates

2019-10-30 16:02:00 | AtriCure Reports Third Quarter 2019 Financial Results

2019-10-27 14:02:27 | Is AtriCure Inc. ATRC A Good Stock To Buy ?

2019-10-23 10:33:02 | Analysts Estimate AtriCure ATRC to Report a Decline in Earnings: What to Look Out for

2019-10-21 08:00:00 | AtriCure to Participate in Upcoming Investor Conferences

2019-10-09 18:18:23 | This Hedge Fund Returns 22% Annually, Here Are Its Latest Picks

2019-10-08 11:06:12 | Does AtriCure's NASDAQ:ATRC Share Price Gain of 64% Match Its Business Performance?

2019-10-08 08:00:00 | AtriCure to Announce Third Quarter 2019 Financial Results

2019-09-02 15:18:57 | How AtriCure, Inc.'s NASDAQ:ATRC Earnings Growth Stacks Up Against The Industry

2019-08-28 10:50:02 | AtriCure Gains Expanded Labeling for Atriclip, Braces LAA Arm